Practice Aids

Recognizing and Managing Amyloid-Related Imaging Abnormalities (ARIA)

• ARIA Management Algorithm
• ARIA Reporting Templates Point of Care
• Classifying ARIA by Radiographic Severity
• Symptoms Consistent With ARIA That Should Trigger Out-of-Sequence MRI
• MRI Acquisition Protocols to Detect and Monitor ARIA
• Selected Images of Amyloid-Related Imaging Abnormalities (ARIA) and Its Mimics
• Triage Strategy for Severe Symptomatic Cases of ARIA

Current and Emerging AD Biomarkers

• Alzheimer’s Disease Cerebrospinal Fluid Biomarkers
• Appropriate Use of AD Biomarkers by Modality
• Commercially Available Biomarkers for AD
• Commercially Available Plasma Biomarkers for AD
• Investigational Fluid Biomarkers

APOE Genotype Testing and Counseling

• APOE Genotype Testing and Counseling Patient Communication Tool for the Multidisciplinary AD Team Point of Care
• APOE ε4 and Late-Onset Alzheimer’s Disease

Screening for Cognitive Impairment

• Clinical Stages of Alzheimer’s Disease
• Cognitive Assessment and Care Planning Services (CACP) CPT 99483
• Criteria for the Diagnosis of Mild Cognitive Impairment (MCI)
• Screening for Cognitive Impairment in Primary Care
• Standardized Tools for Assessing for Cognitive or Functional Impairment With Sensitivity to Detect MCI
• Disclosing a Diagnosis of MCI or Early Dementia
• FDA-Approved Digital Cognitive Assessment Tools

Biological Diagnosis and Staging Guidelines

• Integrated Biological and Clinical Staging of AD
• AT(N) Biomarker Stage and Cognitive Stage Classification
• Revised Criteria for Biomarker-Based Diagnosis and Staging of AD
• Diagnosis of MCI Due to AD and Early AD- Stepwise Approach

Diagnostic PET Imaging Resources

• Alzheimer’s Disease Internet Resources for Radiology and Nuclear Medicine Specialists
• Amyloid PET Imaging Practice Aid
• Amyloid PET Reporting Template Point of Care
• Diagnostic Algorithm for Early and Differential Diagnoses of Dementia
• Early Dementia Differential Diagnosis Using 18F-FDG PET Images
• Structural and Functional Neuroimaging Techniques for Studying Brain Changes Associated With AD
• Tau PET Imaging Practice Aid

Integrating ATTs Into Practice

• Anti-Amyloid Monoclonal Antibody Infusion Order Form Point of Care
• Appropriate Use of Anti-Aβ Monoclonal Antibodies in Clinical Practice
• Baseline MRI-Based Exclusion Criteria for ATTs
• Mechanisms of Action of the Main Anti-Aβ Drugs That Are in Clinical Development for the Treatment of Alzheimer’s Disease
• Prior Authorization Request Form for Anti-Amyloid Therapy Point of Care
• Resources Needed by a Clinician or Medical Center for the Safe and Effective Use of Anti-Aβ Monoclonal Antibodies in Clinical Practice
• Shared Decision-Making Discussion With Patients and Caregivers Regarding Current and Emerging Anti-Amyloid Monoclonal Antibodies
• Workflow in a Collaborative, Multidisciplinary AD Care Team